2.4 ML risankizumab-rzaa 150 MG/ML Cartridge

RxNorm concept 2604625, clinical drug (scd). Prescribable name: risankizumab-rzaa 360 MG in 2.4 ML Cartridge.

RxCUI: 2604625
Term type: Clinical drug (SCD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/2604625 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

risankizumab 2166040

Other names

risankizumab-rzaa 360 MG per 2.4 ML Cartridge

Related concepts

risankizumab-rzaa 150 MG/ML (SCDC, consists of)
Cartridge (DF, has dose form)
2.4 ML risankizumab-rzaa 150 MG/ML Cartridge [Skyrizi] (SBD, has tradename)

Linked data

NDCs

RxNorm links no NDCs to this concept.

Use it

Look up 2604625 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/2604625 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 2604625. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.